Z ZEVRA THERAPEUTICS, INC.: management transactions · United States · SEC (Form 4) Browse the full directors' dealings record of ZEVRA THERAPEUTICS, INC., a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). Market capitalisation: €668.6m. The latest transaction was disclosed on 31 March 2025 (Acquisition). Among the most active insiders: Clifton R. LaDuane. All data is openly available.
€449,705
23 ops.
Buy Volume
€648,590
4 ops.
Sell Volume
Buys €449,705 €648,590 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 31 March 2025
All Executives31 Thresholds0 Prospectus0 Other0
Declarations 31 total
▲ Director · Executives · 28 Mar 2025
300 shares @ US$7.8384 20.1% of flow Common Stock SEC:0001437749-25-010332:0
Ideal exit: 23 Dec 2025 (T+270) ▲ Director · Executives · 19 Mar 2025
10,000 shares @ US$7.9624 40.2% of flow Common Stock SEC:0001437749-25-008738:0
Ideal exit: 14 Dec 2025 (T+270) ▼ President and CEO · Executives · 13 Feb 2025
61,273 shares @ US$7.8571 100.0% of flow Common Stock SEC:0001437749-25-004067:0
▼ CCO & EVP, Bus. Development · Executives · 13 Feb 2025
10,500 shares @ US$7.8597 83.2% of flow Common Stock SEC:0001437749-25-004069:0
▼ SVP, Finance & Corp Controller · Executives · 13 Feb 2025
3,000 shares @ US$7.8626 84.1% of flow Common Stock SEC:0001437749-25-004070:0
▼ CFO & Treasurer · Executives · 13 Feb 2025
11,000 shares @ US$7.861 77.6% of flow Common Stock SEC:0001437749-25-004068:0
◇ President and CEO · Executives · 31 Jan 2025
233,333 shares Common Stock SEC:0001437749-25-002623:0
◇ SVP, Finance & Corp Controller · Executives · 31 Jan 2025
11,666 shares Common Stock SEC:0001437749-25-002629:0
◇ CFO & Treasurer · Executives · 31 Jan 2025
43,333 shares Common Stock SEC:0001437749-25-002625:0
◇ CCO & EVP, Bus. Development · Executives · 31 Jan 2025
35,333 shares Common Stock SEC:0001437749-25-002627:0
▲ Director · Executives · 11 Oct 2024
500 shares @ US$7.9153 33.3% of flow Common Stock SEC:0001437749-24-031367:0
Ideal exit: 8 Jul 2025 (T+270) ▲ CFO & Treasurer · Executives · 17 Jul 2024
2,000 shares @ US$6.77 11.5% of flow Common Stock SEC:0001437749-24-022939:0
Ideal exit: 13 Apr 2025 (T+270) ▲ Director · Executives · 16 Jul 2024
10,000 shares @ US$6.8065 57.9% of flow Common Stock SEC:0001437749-24-022829:0
Ideal exit: 12 Apr 2025 (T+270) ▲ Director · Executives · 12 Jul 2024
10,000 shares @ US$5.8661 29.8% of flow Common Stock SEC:0001437749-24-022734:0
Ideal exit: 8 Apr 2025 (T+270) ▲ CFO, Secretary & Treasurer · Executives · 6 Sept 2023
1,000 shares @ US$4.9591 4.3% of flow Common Stock SEC:0001437749-23-025317:0
Ideal exit: 2 Jun 2024 (T+270) ▲ CCO & EVP, Bus. Development · Executives · 5 Sept 2023
500 shares @ US$5.129 2.5% of flow Common Stock SEC:0001437749-23-025318:0
Ideal exit: 1 Jun 2024 (T+270) ▲ Director · Executives · 6 Sept 2023
10,000 shares @ US$4.8764 42.1% of flow Common Stock SEC:0001437749-23-025312:0
Ideal exit: 2 Jun 2024 (T+270) ▲ Director · Executives · 5 Sept 2023
10,000 shares @ US$5.1333 26.4% of flow Common Stock SEC:0001437749-23-025313:0
Ideal exit: 1 Jun 2024 (T+270) ▲ CCO & EVP, Bus. Development · Executives · 19 May 2023
1,000 shares @ US$5.4157 5.3% of flow Common Stock SEC:0001437749-23-019035:0
Ideal exit: 13 Feb 2024 (T+270) ▲ Director · Executives · 23 Jun 2023
275 shares @ US$5.9479 13.7% of flow Common Stock SEC:0001437749-23-018447:0
Ideal exit: 19 Mar 2024 (T+270) ▲ Director · Executives · 9 Jun 2023
325 shares @ US$5.52 15.3% of flow Common Stock SEC:0001437749-23-017335:0
Ideal exit: 5 Mar 2024 (T+270) ▲ Director · Executives · 30 May 2023
400 shares @ US$5.1053 17.5% of flow Common Stock SEC:0001437749-23-016221:0
Ideal exit: 24 Feb 2024 (T+270) ▲ Director · Executives · 18 May 2023
1,390 shares @ US$5.035 3.6% of flow Common Stock SEC:0001437749-23-015335:0
Ideal exit: 12 Feb 2024 (T+270) ▲ CFO, Secretary & Treasurer · Executives · 18 May 2023
51 shares @ US$4.94 0.2% of flow Common Stock SEC:0001437749-23-015140:0
Ideal exit: 12 Feb 2024 (T+270) ▲ Director · Executives · 17 Mar 2023
519 shares @ US$4.8215 100.0% of flow Common Stock SEC:0001437749-23-007397:0
Ideal exit: 12 Dec 2023 (T+270) 25 of 31 declarations
Load more (6 remaining)